Literature DB >> 6193256

Hypervolemic hemodilution in experimental focal cerebral ischemia. Elevation of cardiac output, regional cortical blood flow, and ICP after intravascular volume expansion with low molecular weight dextran.

J H Wood, F A Simeone, E A Fink, M A Golden.   

Abstract

Cerebrovascular and cardiac alterations evoked by intravascular volume expansion with low molecular weight dextran (LMD, molecular weight 40,000), an advocated adjunct in the clinical prevention or therapy of acute stroke and cerebral vasospasm, were studied in splenectomized dogs. Clipping of the right distal internal carotid artery and the proximal middle cerebral artery (MCA) in eight dogs decreased regional cortical blood flow (rCoBF) by 58% without changing cardiac output (CO), and caused 10% +/- 5% (SE) hemispheric infarction. Ten other dogs underwent similar cerebral arterial occlusion and were infused twice with LMD within 2 hours; each infusion equaled 20% of the respective dog's total blood volume. Both CO and rCoBF in the territory of the occluded MCA increased significantly by 119% +/- 13% and 42% +/- 6%, respectively. following the two LMD infusions. Although the mean arterial blood pressure was unaltered, the hematocrit decreased significantly and the intracranial pressure (ICP) increased significantly. The mean hemispheric infarction in these 10 treated dogs was 4% +/- 2%. Another nine dogs underwent arterial manipulation without clipping. Two hemodiluting LMD infusions, similar to those in the 10 dogs, significantly elevated CO and ICP but not rCoBF. These data suggest that hypervolemic hemodilution with LMD effectively elevates collateral perfusion to ischemic regions of brain distal to occluded MCA segments and concomitantly raises the CO and ICP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193256     DOI: 10.3171/jns.1983.59.3.0500

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

1.  Effect of hypervolaemic haemodilution of regional cerebral blood flow in patients with acute ischaemic stroke: a controlled study with hydroxyethylstarch.

Authors:  A Hartmann; Y Tsuda; H Lagrèze
Journal:  J Neurol       Date:  1987-10       Impact factor: 4.849

2.  Haemodilution with dextran 40 and hydroxyethyl starch and its effect on cerebral microcirculation.

Authors:  J Scharf; R von Kummer; T Back; H Reich; G Machens; B Wildemann
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

Review 3.  Drug treatment of stroke. Current status and future prospects.

Authors:  C A Sila; A J Furlan
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

4.  High dose human serum albumin for the treatment of acute ischemic stroke: a safety study.

Authors:  Sebastian Koch; Mauricio Concha; Tarek Wazzan; Jose G Romano; Alejandro Forteza
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

5.  Rapid natriuresis and preventive hypervolaemia for symptomatic vasospasm after subarachnoid haemorrhage.

Authors:  K Okuchi; M Fujioka; A Fujikawa; A Nishimura; T Konobu; S Miyamoto; T Sakaki
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage.

Authors:  H Otsubo; T Takemae; T Inoue; S Kobayashi; K Sugita
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

7.  A controlled study of Dextran 40: effect on cerebral blood flow and metabolic rates in acute head trauma.

Authors:  F Artru; B Philippon; E Flachaire; J C Peyrieux; J P Boissel; S Ferry; R Deleuze
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.